Total Payments
$6,279
2024 Payments
$1,895
Companies
39
Transactions
472
Medicare Patients
546
Medicare Billing
$31,973
Payment Breakdown by Category
Food & Beverage$6,264 (99.8%)
Education$14.66 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,264 | 471 | 99.8% |
| Education | $14.66 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $967.90 | 97 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $768.67 | 69 | $0 (2024) |
| Lilly USA, LLC | $576.28 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $410.31 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $344.99 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $299.52 | 19 | $0 (2024) |
| PFIZER INC. | $276.31 | 18 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $199.32 | 19 | $0 (2022) |
| Novo Nordisk Inc | $191.40 | 12 | $0 (2024) |
| Currax Pharmaceuticals LLC | $185.34 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,895 | 132 | ABBVIE INC. ($404.35) |
| 2023 | $1,748 | 124 | ABBVIE INC. ($355.30) |
| 2022 | $1,324 | 105 | Takeda Pharmaceuticals U.S.A., Inc. ($217.57) |
| 2021 | $1,311 | 111 | Takeda Pharmaceuticals U.S.A., Inc. ($345.70) |
All Payment Transactions
472 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Obesity | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Obesity | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Cranial Orthotic | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 149 | 220 | $34,464 | $10,137 |
| 2022 | 6 | 148 | 213 | $36,507 | $6,914 |
| 2021 | 6 | 136 | 222 | $35,411 | $7,407 |
| 2020 | 4 | 113 | 159 | $28,708 | $7,515 |
Total Patients
546
Total Services
814
Medicare Billing
$31,973
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 65 | $18,494 | $4,243 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $8,060 | $2,916 | 36.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 15 | $2,059 | $1,126 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $3,414 | $812.06 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 79 | $2,054 | $663.60 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 16 | $384.00 | $376.32 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 68 | $19,128 | $2,681 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 34 | $6,777 | $1,541 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $7,171 | $1,409 | 19.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $1,510 | $772.75 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $336.00 | $329.28 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 61 | $1,586 | $181.05 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 81 | $22,463 | $4,129 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,421 | $1,439 | 26.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 25 | $4,826 | $1,124 | 23.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 13 | 14 | $596.78 | $284.57 | 47.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 14 | $336.00 | $226.54 | 67.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 38 | 68 | $1,768 | $204.00 | 11.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 64 | $15,232 | $3,747 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 20 | 20 | $5,040 | $1,936 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 47 | $7,708 | $1,750 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 24 | 28 | $728.00 | $81.18 | 11.2% |
About Audrey Baker
Audrey Baker is a Family healthcare provider based in New Lexington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1598296972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Audrey Baker has received a total of $6,279 in payments from pharmaceutical and medical device companies, with $1,895 received in 2024. These payments were reported across 472 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,264).
As a Medicare-enrolled provider, Baker has provided services to 546 Medicare beneficiaries, totaling 814 services with total Medicare billing of $31,973. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location New Lexington, OH
- Active Since 03/27/2017
- Last Updated 03/27/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1598296972
Products in Payments
- TRINTELLIX (Drug) $718.57
- NURTEC ODT (Drug) $499.24
- VRAYLAR (Drug) $422.19
- JARDIANCE (Drug) $344.24
- UBRELVY (Drug) $323.98
- FARXIGA (Drug) $234.37
- REXULTI (Drug) $204.78
- QULIPTA (Drug) $182.01
- CAPLYTA (Drug) $181.61
- Cologuard Collection Kit (Device) $162.39
- MOUNJARO (Drug) $157.75
- ZENPEP (Drug) $156.48
- XIFAXAN (Drug) $153.43
- Kerendia (Drug) $136.66
- EMGALITY (Drug) $122.20
- TRULICITY (Drug) $117.99
- FREESTYLE LIBRE 3 (Device) $116.81
- LATUDA (Drug) $114.41
- SPIRIVA RESPIMAT (Drug) $113.56
- ELIQUIS (Drug) $105.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in New Lexington
Katie Billingsley, Np-C, NP-C
Family — Payments: $4,863
Family $4,863
Mrs. Christy Hill, Cnp, CNP
Family — Payments: $4,224
Family $4,224
Mrs. Donna Mayer, Cnp, CNP
Family — Payments: $4,136
Family $4,136
Mr. John Miller, Cnp, CNP
Family — Payments: $4,060
Family $4,060
Brittney Valentine, Fnp-Bc, FNP-BC
Family — Payments: $2,256
Family $2,256
Carlie Woodard, Np-C, NP-C
Family — Payments: $2,233
Family $2,233